Stay updated on ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedPage revision updated from v3.6.2 to v3.6.3, indicating a minor backend or display update. The visible study information and user actions remain unchanged.SummaryDifference0.0%

- Check25 days agoChange DetectedA broader set of keywords/MeSH terms and drug names was added to the study's metadata (e.g., Bevacizumab, Gemcitabine, Paclitaxel, Carboplatin, pegylated liposomal doxorubicin), enhancing indexing and cross-linking. The revision tag was updated from v3.6.0 to v3.6.2.SummaryDifference79%

- Check40 days agoChange DetectedNew user-focused sections and links were added to help potential participants determine eligibility, contact the study team, and learn how to join. Existing content labeling was standardized to present the Interventions/Treatment clearly.SummaryDifference0.4%

- Check47 days agoChange DetectedThe page revision line was updated from v3.5.4 to v3.5.5, indicating a new site deployment rather than changes to the study details.SummaryDifference0.0%

- Check68 days agoChange DetectedThe revision label at the bottom of the page updated from v3.5.3 to v3.5.4, indicating a site deployment. This update does not alter the study details or user-facing functionality.SummaryDifference0.0%

- Check90 days agoChange DetectedThe page’s displayed software/version label has been updated from **Revision v3.5.2** to **Revision v3.5.3**, indicating an interface or site release update without affecting the underlying study record content.SummaryDifference0.0%

Stay in the know with updates to ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial page.